Andy Pierce shares how Stryker is “fighting on its front foot” through R&D and aggressive M&A
Description
In this StrykerTalks episode, Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, shares his insights on the company’s commitment to innovation, growth, and patient-centered care.
Pierce reflects on his 29-year journey with Stryker, highlighting the high-performance culture shaped by entrepreneurial spirit, growth targets, and strategic acquisitions. He discusses how Stryker’s decentralized structure supports quick, localized decision-making while fostering collaboration across its business units.
The conversation also explores the company's M&A strategy, focusing on acquisitions that bring de-risked, high-impact technologies that align with Stryker’s long-term goals. Pierce provides an inside look at Stryker's engagement with the soft tissue robotics space, its approach to balancing internal and external innovation, and the proactive steps Stryker takes to address healthcare staffing shortages with technology.
Thank you to Vantedge Medical for sponsoring this episode. To learn more about how Vantedge Medical works with medical device companies, visit www.vantedgemedical.com
Thank you for listening to the StrykerTalks Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Kit Yee Au-Yeung, general manager of AQMed at SandBoxAQ, an Alphabet spinout using AI and sensors to develop new tools in several industries.
Sandbox’s medical group is using these new technologies to develop advanced AI-powered...
Published 11/22/24
In this episode of Structural Heart Talks, Larry Wood, Corporate VP and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart at Edwards Lifesciences, discusses the transformative journey of transcatheter aortic valve replacement (TAVR) and the SAPIEN valve. Wood...
Published 11/17/24